Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on TEVA PHARMACEUTICAL INDUST
5d ago Actavis to buy Warner Chilcott in $5 billion stock deal
5d ago TEVA PHARMACEUTICAL INDUSTRIES LIMIT: ex-dividend day for interim dividend
05/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva to Present at the Bank of America Me..
05/08DJTeva, Alexza Pharmaceuticals In Inhaler Licensing Pact
05/08 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: New Data Presented Demonstrates Ovulatory..
05/08DJTeva Pharmaceutical, Alexza Pharmaceuticals Reach Licensing Pact for Adasuve
05/08 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva and Alexza Announce Teva's License t..
05/06 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Women's Health to Present New Data a..
05/02DJTeva Pharmaceutical's Profit Falls on Lower Generic Sales
05/02DJTeva Profit Falls 27% on Lower Generic Sales
05/02DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Pharmaceutical 1st-Quarter Net Falls..
05/02 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Reports First Quarter 2013 Results
04/30 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: FDA Approves Over-The-Counter Availabilit..
04/30DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: FDA Approves Teva's Plan B Pill for Women..
04/29 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Expands Management Team with Appoint..
04/29 Bayer to buy birth-control devices maker for $1.1 billion
04/26TEVA PHARMACEUTICAL INDUSTRIES LIMIT: quaterly earnings release
04/24DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Creates Specialty-Medicines Division..
04/24 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Establishes Global Specialty Medicin..
04/23DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Gets Orphan Drug Designation for XEN..
04/23 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva and Xenon Announce FDA Orphan Drug D..
04/17 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Big News: Teva Pharmaceutical Industries,..
04/17 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Presented New Data from Phase III Cl..
04/10DJSome Drug Makers Cut Payments, Meals Provided to Doctors
04/10DJSome Drug Makers Cut Payments, Meals Provided to Doctors
04/09 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva to Report First Quarter 2013 Financi..
04/08DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Correction to Plan B Contraceptive Story ..
04/08 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva-Handok Names Yoo Suk Hong as Chief E..
04/08 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Names Ichiro Kikushige as CEO of Tev..
04/03DJActavis Temporarily Enjoined From Selling Generic of AstraZeneca's Pulmicort ..
04/03 AstraZeneca wins temporary block on Actavis asthma drug
04/02 AstraZeneca suffers fresh drug patent setback in U.S.
04/02DJCourt Rules AstraZeneca's U.S. Pulmicort Patent Invalid
04/02DJCourt Rules AstraZeneca's U.S. Pulmicort Patent Invalid
03/29 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: FDA Approves New Drug Application (NDA) f..
03/27DJ2ND UPDATE: FDA Approves Biogen's Pill to Treat Multiple Sclerosis
03/27DJCorrection to Stories About FDA's Approval of Biogen's MS Pill
03/27DJFDA Approves Biogen's Pill to Treat Multiple Sclerosis
03/27DJFDA Approves Biogen Treatment for MS
03/25 Analysis - Roche stays a step ahead of copycat drugmakers
03/21DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva and Active Biotech See Positive Resu..
03/21 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Early versus Delayed Treatment with Laqui..
03/20DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Will Try To Prevent Sedative From Be..
03/20DJTeva Pharmaceutical Parkinson's Treatment Meets Study Goals
03/20 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: New Data Show Azilect® (rasagiline tablet..
03/15DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/15DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/14DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva To Pay $2.25 Million To Resolve Miss..
03/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva to Present New Research on CNS Produ..
03/12 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva to Present at the 2013 Barclays Glob..
03/08 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Files 2012 Annual Report on Form 20-..
03/06 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: First Patient Enrolled in Third Phase III..
03/05DJPfizer Gets Reissued Celebrex Patent, Extends Exclusivity
03/05DJPfizer Get Reissued Patent for Celebrex
03/05DJPfizer Get Reissued Patent for Celebrex; Extends Exclusivity to 2015
03/04 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Phase III Study of Teva's Milprosa? (Prog..
03/01 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Calls 5.550% Senior Notes Due 2016 f..
02/25 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva to Present at the 2013 RBC Capital M..
02/22 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Additional QNASL® (beclomethasone dipropi..
02/22DJWhy Your Boss Is Dumping Your Spouse...From Your Health Coverage
02/21 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: ex-dividend day for interim dividend
02/20DJGilead, Teva Reach Preliminary Pact in Viread Patent Dispute
02/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Announces FDA Approval of Generic Ad..
02/13DJTeva Faces Damages From Selling Generic Protonix
02/13DJTeva Faces Damages Up to $2.1 Billion From Selling Generic Protonix
02/12DJJudge Rules Bristol-Myers Patent for Liver Drug is Invalid
02/11 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Pharmaceuticals Announces Appointmen..
02/07DJTeva Pharmaceutical 4th-Quarter Profit Off 37% Amid Weaker Generic Sales
02/07DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Pharmaceutical Profit Off 37%
02/07DJTEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Pharmaceutical 4th-Quarter Profit Of..
02/07 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Reports Fourth Quarter and Full Year..
02/06DJConcerns Rise Ahead of Amgen's Business Update Thursday
02/06DJBiogen to Buy Elan's Stake in MS Drug Tysabri
02/06DJBiogen to Buy Elan Stake in Drug Tysabri for $3.25 Billion
02/05 TEVA PHARMACEUTICAL INDUSTRIES LIMIT: Teva Announces First Patient Enrolled in ..
1  2  3  4  5Next
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
Teva Pharmaceutical Indust : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.